NanoString Technologies

Inside NanoString's deal with Merck: $12M in cash and a roadmap for expansion
Bizjournals.com
Wed, 03/2/16 - 11:44 am
Merck
NanoString Technologies
R&D
PAM50-Based Prosigna Breast Cancer Assay Helps to Identify Patients at Risk of Late Distant Recurrence in a Combined Analysis of 2,137 Patients
Yahoo/BusinessWire
Sat, 12/14/13 - 11:50 am
Prosigna Breast Cancer Prognostic Gene Signature Assay
NanoString Technologies
breast cancer
NanoString Technologies: An Emerging Growth Play In Molecular Diagnostics
Seeking Alpha
Tue, 11/26/13 - 04:33 pm
NanoString Technologies
molecular diagnostics
NanoString: An Exciting Small Cap Story With A Strong Growth Outlook
Seeking Alpha
Mon, 09/23/13 - 09:41 am
NanoString Technologies
A Time to Test Biotechs' Strength
The Street
Sun, 08/25/13 - 11:31 am
Bluebird Bio
Epizyme
Intrexon
NanoString Technologies
LipoScience
Aratana
Heat Biologics
ONYX Pharmaceuticals
Amgen